Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.00)
# 2,930
Out of 4,740 analysts
734
Total ratings
34.54%
Success rate
-6.59%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RIGL Rigel Pharmaceuticals | Reiterates: Buy | $57 | $21.82 | +161.23% | 25 | Jan 23, 2025 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $2.11 | +658.33% | 24 | Jan 23, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $120 | $47.25 | +153.97% | 44 | Jan 22, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $34.03 | +199.70% | 27 | Jan 17, 2025 | |
| BMEA Biomea Fusion | Reiterates: Buy | $40 | $4.33 | +824.86% | 25 | Jan 16, 2025 | |
| APRE Aprea Therapeutics | Reiterates: Buy | $20 | $4.06 | +392.32% | 14 | Jan 15, 2025 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $18 | $1.26 | +1,328.57% | 13 | Jan 14, 2025 | |
| VYNE VYNE Therapeutics | Reiterates: Buy | $5.75 | $2.73 | +110.62% | 19 | Jan 14, 2025 | |
| ATXS Astria Therapeutics | Reiterates: Buy | $16 | $7.53 | +112.62% | 16 | Jan 13, 2025 | |
| PHGE BiomX | Reiterates: Buy | $2 | $0.81 | +146.91% | 12 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.06 | +226.80% | 16 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.20 | +886.19% | 15 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $123 | $25.75 | +377.66% | 20 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $14.53 | +429.94% | 18 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $23.95 | +234.03% | 29 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.97 | +1,654.20% | 25 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.25 | +211.11% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $221 | $151.27 | +46.10% | 25 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $1.56 | +1,250.48% | 26 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.15 | +1,065.50% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $9.09 | +307.04% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.92 | +586.11% | 17 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.59 | +478.32% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $115.13 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.47 | +910.10% | 6 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.67 | +1,392.76% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.28 | - | 7 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $0.66 | +1,269.86% | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $9 | $0.11 | +7,978.99% | 11 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $37 | $7.94 | +365.99% | 23 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.85 | +1,309.21% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.32 | +203.95% | 22 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.19 | - | 17 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.18 | +246.46% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $4.72 | +557.06% | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.93 | +446.08% | 9 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $0.88 | +5,216.74% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.94 | +537.42% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $19.19 | +66.80% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.08 | +332.17% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $5.94 | +439.17% | 26 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.10 | +509.76% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $6.34 | +231.23% | 7 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $4.14 | -51.69% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.74 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.74 | +1,739.08% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.98 | +905.43% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $9 | $12.43 | -27.57% | 2 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.41 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $29.14 | +13.27% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.59 | +1,295.35% | 1 | Mar 24, 2017 |
Rigel Pharmaceuticals
Jan 23, 2025
Reiterates: Buy
Price Target: $57
Current: $21.82
Upside: +161.23%
Esperion Therapeutics
Jan 23, 2025
Reiterates: Buy
Price Target: $16
Current: $2.11
Upside: +658.33%
Cytokinetics
Jan 22, 2025
Reiterates: Buy
Price Target: $120
Current: $47.25
Upside: +153.97%
Viking Therapeutics
Jan 17, 2025
Reiterates: Buy
Price Target: $102
Current: $34.03
Upside: +199.70%
Biomea Fusion
Jan 16, 2025
Reiterates: Buy
Price Target: $40
Current: $4.33
Upside: +824.86%
Aprea Therapeutics
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $4.06
Upside: +392.32%
Tenaya Therapeutics
Jan 14, 2025
Reiterates: Buy
Price Target: $18
Current: $1.26
Upside: +1,328.57%
VYNE Therapeutics
Jan 14, 2025
Reiterates: Buy
Price Target: $5.75
Current: $2.73
Upside: +110.62%
Astria Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $16
Current: $7.53
Upside: +112.62%
BiomX
Jan 10, 2025
Reiterates: Buy
Price Target: $2
Current: $0.81
Upside: +146.91%
Jan 10, 2025
Reiterates: Buy
Price Target: $10
Current: $3.06
Upside: +226.80%
Jan 10, 2025
Reiterates: Buy
Price Target: $2
Current: $0.20
Upside: +886.19%
Jan 7, 2025
Reiterates: Buy
Price Target: $123
Current: $25.75
Upside: +377.66%
Jan 2, 2025
Reiterates: Buy
Price Target: $77
Current: $14.53
Upside: +429.94%
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $23.95
Upside: +234.03%
Dec 19, 2024
Reiterates: Buy
Price Target: $17
Current: $0.97
Upside: +1,654.20%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $2.25
Upside: +211.11%
Dec 18, 2024
Reiterates: Buy
Price Target: $221
Current: $151.27
Upside: +46.10%
Dec 18, 2024
Reiterates: Buy
Price Target: $21
Current: $1.56
Upside: +1,250.48%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.15
Upside: +1,065.50%
Dec 17, 2024
Reiterates: Buy
Price Target: $37
Current: $9.09
Upside: +307.04%
Dec 16, 2024
Reiterates: Buy
Price Target: $20
Current: $2.92
Upside: +586.11%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.59
Upside: +478.32%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $115.13
Upside: -
Dec 10, 2024
Reiterates: Buy
Price Target: $35
Current: $3.47
Upside: +910.10%
Dec 9, 2024
Initiates: Buy
Price Target: $10
Current: $0.67
Upside: +1,392.76%
Dec 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.28
Upside: -
Dec 4, 2024
Maintains: Buy
Price Target: $7 → $9
Current: $0.66
Upside: +1,269.86%
Nov 25, 2024
Maintains: Buy
Price Target: $21 → $9
Current: $0.11
Upside: +7,978.99%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $37
Current: $7.94
Upside: +365.99%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.85
Upside: +1,309.21%
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $1.32
Upside: +203.95%
Nov 15, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $11
Current: $3.18
Upside: +246.46%
Nov 14, 2024
Reiterates: Buy
Price Target: $31
Current: $4.72
Upside: +557.06%
Nov 14, 2024
Reiterates: Buy
Price Target: $16
Current: $2.93
Upside: +446.08%
Nov 13, 2024
Reiterates: Buy
Price Target: $47
Current: $0.88
Upside: +5,216.74%
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $0.94
Upside: +537.42%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $19.19
Upside: +66.80%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $2.08
Upside: +332.17%
Nov 6, 2024
Reiterates: Buy
Price Target: $32
Current: $5.94
Upside: +439.17%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $4.10
Upside: +509.76%
Aug 6, 2024
Reiterates: Buy
Price Target: $21
Current: $6.34
Upside: +231.23%
May 16, 2024
Reiterates: Buy
Price Target: $2
Current: $4.14
Upside: -51.69%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.74
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.74
Upside: +1,739.08%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.98
Upside: +905.43%
Mar 11, 2020
Reiterates: Buy
Price Target: $11 → $9
Current: $12.43
Upside: -27.57%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.41
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $29.14
Upside: +13.27%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.59
Upside: +1,295.35%